Based on the in vitro efficacy of 5b in GBA1-PD patient-derived iPSC neurons, we tested in vivo whether long-term 5b treatment could ameliorate the observed motor phenotypes, GCase maturation, and αS dyshomeostasis in Gba1 mutant mice. The gene discussed is GBA1; the disease is Parkinson disease.